Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2.
Saved in:
| Title: | Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2. |
|---|---|
| Authors: | Kuczynski LE; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Shallow JR; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Watson MP; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Homsy ML; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Svab T; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA., Gruber A; Analytical Research & Development, MRL, Merck & Co., Inc, West Point, Pennsylvania, USA., Rustandi RR; Analytical Research & Development, MRL, Merck & Co., Inc, West Point, Pennsylvania, USA., Hu J; Center of Mathematical Sciences, MMD, Merck & Co., Inc., West Point, Pennsylvania, USA., Winters MA; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA. |
| Source: | Biotechnology journal [Biotechnol J] 2024 Jan; Vol. 19 (1), pp. e2300041. Date of Electronic Publication: 2023 Oct 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 101265833 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7314 (Electronic) Linking ISSN: 18606768 NLM ISO Abbreviation: Biotechnol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37766672 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kuczynski+LE%22">Kuczynski LE</searchLink>; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Shallow+JR%22">Shallow JR</searchLink>; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Watson+MP%22">Watson MP</searchLink>; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Homsy+ML%22">Homsy ML</searchLink>; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Svab+T%22">Svab T</searchLink>; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Gruber+A%22">Gruber A</searchLink>; Analytical Research & Development, MRL, Merck & Co., Inc, West Point, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Rustandi+RR%22">Rustandi RR</searchLink>; Analytical Research & Development, MRL, Merck & Co., Inc, West Point, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Hu+J%22">Hu J</searchLink>; Center of Mathematical Sciences, MMD, Merck & Co., Inc., West Point, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Winters+MA%22">Winters MA</searchLink>; Vaccine Process Research & Development, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101265833%22">Biotechnology journal</searchLink> [Biotechnol J] 2024 Jan; Vol. 19 (1), pp. e2300041. <i>Date of Electronic Publication: </i>2023 Oct 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-VCH+Verlag%22">Wiley-VCH Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101265833 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1860-7314 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218606768%22">18606768 </searchLink><i>NLM ISO Abbreviation: </i>Biotechnol J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37766672 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/biot.202300041 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2300041 Titles: – TitleFull: Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kuczynski LE – PersonEntity: Name: NameFull: Shallow JR – PersonEntity: Name: NameFull: Watson MP – PersonEntity: Name: NameFull: Homsy ML – PersonEntity: Name: NameFull: Svab T – PersonEntity: Name: NameFull: Gruber A – PersonEntity: Name: NameFull: Rustandi RR – PersonEntity: Name: NameFull: Hu J – PersonEntity: Name: NameFull: Winters MA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2024 Jan Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1860-7314 Numbering: – Type: volume Value: 19 – Type: issue Value: 1 Titles: – TitleFull: Biotechnology journal Type: main |
| ResultId | 1 |